← Back to Search

Tele-EaT Sensors for Swallowing Disorders

Phase < 1
Waitlist Available
Led By Georgia A. Malandraki, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post each experiment (i.e., 1 hour after the sensors have been placed)
Awards & highlights

Study Summary

This trial will develop and test new wearable sensors to help people with swallowing disorders, to see if they work as well as traditional sensors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post each experiment (i.e., 1 hour after the sensors have been placed)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post each experiment (i.e., 1 hour after the sensors have been placed) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Normalized task-related sEMG amplitude (signal quality parameter)
Peak pressure during maximum lingual press and swallows (signal quality parameter)
Signal to Noise ratio (signal quality parameter)
Secondary outcome measures
Adverse effects and safety
Ease of use/comfort
Onset of sEMG activity relative to onset of swallow apnea
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental SensorsExperimental Treatment1 Intervention
This arm will include the use of the experimental wearable sensors we are developing.
Group II: Conventional SensorsActive Control1 Intervention
This arm will include the use of the conventional sensors: regular snap on sEMG electrodes and IOPI device bulb.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tele-EaT Sensors
2018
Completed Early Phase 1
~110

Find a Location

Who is running the clinical trial?

Purdue UniversityLead Sponsor
224 Previous Clinical Trials
72,662 Total Patients Enrolled
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
89 Previous Clinical Trials
19,682 Total Patients Enrolled
Georgia A. Malandraki, PhDPrincipal Investigator - Associate Professor
Purdue University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include any older individuals in the sample size?

"The age limit for this study is 90 years old, meaning that as long as patients are over 18, they are eligible for the trial."

Answered by AI

Are there any specific requirements for those who want to be a part of this research?

"This clinical trial is searching for 200 individuals that currently experience esophageal dysphagia. The ideal candidate will be between the ages of 18 and 90. In addition to this age requirement, it is necessary that patients meet the following inclusion criteria: Age 18-90 years of age, Age 18-30 OR 50-90 years of age, No history of a neurological disorder, A score of <3 on the Eating Assessment Tool-10 (EAT-10, a self-report screening for dysphagia)., A score in the normal/mild range on the Montreal Cognitive Assessment (MoCA)., A"

Answered by AI

How many total test subjects are involved in this experiment?

"That is correct. The clinical trial is still recruiting patients, as shown by the most recent update on clinicaltrials.gov. The posting date was September 11th, 2018, and the 200 patients are needed at a single site."

Answered by AI
~15 spots leftby Apr 2025